Clinical equipoise and the incoherence of research ethics.
The doctrine of clinical equipoise is appealing because it appears to permit physicians to maintain their therapeutic obligation to offer optimal medical care to patients while conducting randomized controlled trials (RCTs). The appearance, however, is deceptive. In this article we argue that clinical equipoise is defective and incoherent in multiple ways. First, it conflates the sound methodological principle that RCTs should begin with an honest null hypothesis with the questionable ethical norm that participants in these trials should never be randomized to an intervention known to be inferior to standard treatment. Second, the claim that RCTs preserve the therapeutic obligation of physicians misrepresents the patient-centered orientation of medical care. Third, the appeal to clinical equipoise as a basic principle of risk-benefit assessment for RCTs is incoherent. Finally, the difficulties with clinical equipoise cannot be resolved by viewing it as a presumptive principle subject to exceptions. In the final sections of the article, we elaborate on the non-exploitation framework for the ethics clinical research and indicate issues that warrant further inquiry.
Miller
Franklin G
FG
Department of Clinical Bioethics Clinical Center, National Institutes of Health, Bethesda, Maryland 20892-1156, USA. fmiller@nih.gov
Brody
Howard
H
D032984:Ethics, Research; D006801:Humans; D010919:Placebos; D016032:Randomized Controlled Trials as Topic / Q000941:ethics*; D018570:Risk Assessment; D036302:Therapeutic Human Experimentation / Q000941:ethics; D035501:Uncertainty
D010919:Placebos